1,801–1,850 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
1801	AIRE	autoimmune regulator	21	OMIM Disease GeneVariant-Rich	225
1802	APOBEC3B	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	22	TrendingExperimental GO Evidence	225
1803	BNIP3	BCL2 interacting protein 3	10	TrendingExperimental GO Evidence	225
1804	CCND3	cyclin D3	6	Experimental GO EvidenceSwiss-Prot Reviewed	225
1805	CSF3	colony stimulating factor 3	17	TrendingExperimental GO Evidence	225
1806	DHFR	dihydrofolate reductase	5	FDA Approved TargetOMIM Disease Gene	225
1807	HNRNPA0	heterogeneous nuclear ribonucleoprotein A0	5	Experimental GO EvidenceSwiss-Prot Reviewed	225
1808	MSTN	myostatin	2	Clinical TrialsOMIM Disease Gene	225
1809	NKX2-5	NK2 homeobox 5	5	Highly ConstrainedTranscription Factor	225
1810	NUP214	nucleoporin 214	9	OncogeneTransporter	225
1811	RAB8A	RAB8A, member RAS oncogene family	19	Highly ConstrainedOncogene	225
1812	RPL36	ribosomal protein L36	19	FDA Approved TargetSwiss-Prot Reviewed	225
1813	TTK	TTK protein kinase	6	KinaseEarly Pipeline	225
1814	ARHGDIA	Rho GDP dissociation inhibitor alpha	17	OMIM Disease GeneExperimental GO Evidence	224
1815	DCD	dermcidin	12	ProteaseExperimental GO Evidence	224
1816	E2F3	E2F transcription factor 3	6	Clinical TrialsExperimental GO Evidence	224
1817	EIF2S3	eukaryotic translation initiation factor 2 subunit gamma	X	Highly ConstrainedOMIM Disease Gene	224
1818	PCMT1	protein-L-isoaspartate (D-aspartate) O-methyltransferase	6	TrendingExperimental GO Evidence	224
1819	RBBP8	RB binding protein 8, endonuclease	18	DNA RepairHomologous Recombination	224
1820	RPL26	ribosomal protein L26	17	Highly ConstrainedFDA Approved Target	224
1821	RPL35	ribosomal protein L35	9	FDA Approved TargetOMIM Disease Gene	224
1822	SEC16A	SEC16 homolog A, endoplasmic reticulum export factor	9	TransporterExperimental GO Evidence	224
1823	SNRPE	small nuclear ribonucleoprotein polypeptide E	1	OMIM Disease GeneExperimental GO Evidence	224
1824	TFEB	transcription factor EB	6	Transcription FactorExperimental GO Evidence	224
1825	TLR1	toll like receptor 1	4	ReceptorExperimental GO Evidence	224
1826	TPR	translocated promoter region, nuclear basket protein	1	Highly ConstrainedOncogene	224
1827	CIITA	class II major histocompatibility complex transactivator	16	KinaseOMIM Disease Gene	223
1828	CLIC1	chloride intracellular channel 1	6	Ion ChannelTransporter	223
1829	FABP2	fatty acid binding protein 2	4	TransporterExperimental GO Evidence	223
1830	HNRNPDL	heterogeneous nuclear ribonucleoprotein D like	4	OMIM Disease GeneExperimental GO Evidence	223
1831	IRS4	insulin receptor substrate 4	X	OMIM Disease GeneExperimental GO Evidence	223
1832	NACA	nascent polypeptide associated complex subunit alpha	12	TransporterExperimental GO Evidence	223
1833	RPL34	ribosomal protein L34	4	FDA Approved TargetExperimental GO Evidence	223
1834	THY1	Thy-1 cell surface antigen	11	Experimental GO EvidenceSwiss-Prot Reviewed	223
1835	WDR77	WD repeat domain 77	1	Experimental GO EvidenceSwiss-Prot Reviewed	223
1836	AIMP1	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	4	OMIM Disease GeneExperimental GO Evidence	222
1837	APAF1	apoptotic peptidase activating factor 1	12	Experimental GO EvidenceSwiss-Prot Reviewed	222
1838	CKAP5	cytoskeleton associated protein 5	11	Highly ConstrainedTrending	222
1839	FLOT2	flotillin 2	17	Experimental GO EvidenceSwiss-Prot Reviewed	222
1840	GAB1	GRB2 associated binding protein 1	4	OMIM Disease GeneExperimental GO Evidence	222
1841	GSTA1	glutathione S-transferase alpha 1	6	Experimental GO EvidenceSwiss-Prot Reviewed	222
1842	H2AZ1	H2A.Z variant histone 1	4	Experimental GO EvidenceSwiss-Prot Reviewed	222
1843	KPNA3	karyopherin subunit alpha 3	13	Highly ConstrainedTransporter	222
1844	OXT	oxytocin/neurophysin I prepropeptide	20	Experimental GO EvidenceSwiss-Prot Reviewed	222
1845	PAK4	p21 (RAC1) activated kinase 4	19	KinaseEarly Pipeline	222
1846	PSMB2	proteasome 20S subunit beta 2	1	FDA Approved TargetExperimental GO Evidence	222
1847	RTCB	RNA 2',3'-cyclic phosphate and 5'-OH ligase	22	Experimental GO EvidenceSwiss-Prot Reviewed	222
1848	SLC6A2	solute carrier family 6 member 2	16	TransporterFDA Approved Target	222
1849	TACR1	tachykinin receptor 1	2	ReceptorFDA Approved Target	222
1850	TFE3	transcription factor binding to IGHM enhancer 3	X	Highly ConstrainedOncogene	222